Nu-Med Plus (NUMD) Cash & Equivalents (2011 - 2025)
Nu-Med Plus (NUMD) reported Cash & Equivalents of $661.0 for Q4 2025, down 72.14% on a YoY basis from $2373.0 in Q4 2024, and down 66.07% sequentially from $1948.0 in Q3 2025.
Nu-Med Plus (NUMD) Cash & Equivalents (2011 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 15 years of Cash & Equivalents data on file, last reported at $661.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents fell 72.14% year-over-year to $661.0; the trailing twelve-month figure through Dec 2025 stood at $661.0 (down 72.14% YoY), and the FY2025 full-year result was $661.0, down 72.14% from the prior year.
- Cash & Equivalents fell to $661.0 in Q4 2025, from $1948.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $139265.0 in Q1 2021 to a low of $628.0 in Q3 2022.
- A 5-year average of $23974.1 and a median of $6356.0 in 2024 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents tumbled 98.18% in 2022 and jumped 1990.22% in 2023, its largest moves.
- Tracing NUMD's Cash & Equivalents over 5 years: stood at $11675.0 in 2021, then surged by 526.94% to $73195.0 in 2022, then tumbled by 90.7% to $6806.0 in 2023, then plunged by 65.13% to $2373.0 in 2024, then tumbled by 72.14% to $661.0 in 2025.
- Business Quant data shows NUMD's Cash & Equivalents at $661.0 in Q4 2025, $1948.0 in Q3 2025, and $863.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 557.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.03 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 661.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 661.00 |
| Sep 30, 2025 | 1,948.00 |
| Jun 30, 2025 | 863.00 |
| Mar 31, 2025 | 2,373.00 |
| Dec 31, 2024 | 2,373.00 |
| Sep 30, 2024 | 4,041.00 |
| Jun 30, 2024 | 4,041.00 |
| Mar 31, 2024 | 6,356.00 |
| Dec 31, 2023 | 6,806.00 |
| Sep 30, 2023 | 11,088.00 |
| Jun 30, 2023 | 29,957.00 |
| Mar 31, 2023 | 53,029.00 |
| Dec 31, 2022 | 73,195.00 |
| Sep 30, 2022 | 628.00 |
| Mar 31, 2022 | 2,537.00 |
| Dec 31, 2021 | 11,675.00 |
| Sep 30, 2021 | 31,840.00 |
| Jun 30, 2021 | 72,831.00 |
| Mar 31, 2021 | 139,265.00 |
| Dec 31, 2020 | 188,506.00 |